Zobrazeno 1 - 10
of 126
pro vyhledávání: '"SHANKAR PRASAD NAGARAJU"'
Autor:
Divya Datta, Indu Ramachandra Rao, Attur Ravindra Prabhu, Shankar Prasad Nagaraju, Girish Thunga, Rahul Magazine, Shivashankar Kaniyoor Nagri, Raghavendra Shetty, Nisha Abdul Khader, Dharshan Rangaswamy, Srinivas Vinayak Shenoy, Mohan V. Bhojaraja, Asha Kamath
Publikováno v:
Renal Failure, Vol 46, Iss 2 (2024)
Introduction Patients with chronic kidney disease (CKD) are at increased risk of developing tuberculosis (TB). These patients may also be at higher risk of developing antitubercular treatment (ATT)-associated adverse drug reactions (ADRs). Although d
Externí odkaz:
https://doaj.org/article/dd9d41d9d9e54059af254c304f4fdc34
Autor:
Srinivas Vinayak Shenoy, Shankar Prasad Nagaraju, Indu Ramachandra Rao, Mohan V Bhojaraja, Ravindra Prabhu Attur, Dharshan Rangaswamy, Shreya Jayaram, Shilna Muttickal Swaminathan, Sindhura Lakshmi Koulmane Laxminarayana
Publikováno v:
F1000Research, Vol 13 (2024)
Background Haematological abnormalities following renal transplantation are frequently observed and have a significant effect on survival and graft outcomes. The pattern of haematological abnormalities varies globally. Few studies have been conducted
Externí odkaz:
https://doaj.org/article/0182d8ad0835471d96d5e74c6b1d8869
Autor:
Shilna Muttickal Swaminathan, Mohan Varadanayakanahalli Bhojaraja, Ravindra Prabhu Attur, Indu Ramachandra Rao, Dharshan Rangaswamy, Srinivas Vinayak Shenoy, Shankar Prasad Nagaraju
Publikováno v:
Journal of Nephropathology, Vol 13, Iss 4, Pp e21516-e21516 (2024)
Introduction: Rapid progression of diabetic kidney disease (DKD) is a significant concern, particularly in developing countries. It remains uncertain whether histopathological parameters, in addition to clinical factors, can predict DKD progression.
Externí odkaz:
https://doaj.org/article/7e836bbce2a24537ad46201f81efd7c4
Autor:
Shankar Prasad Nagaraju, Shilna Muttickal Swaminathan, Shruti Bhattacharya, Ravindra Prabhu Attur, Dharshan Rangaswamy, Indu Ramachandra Rao, Srinivas Vinayak Shenoy, Mohan Varadanayakanahalli Bhojaraja
Publikováno v:
Oman Medical Journal, Vol 39, Iss 3, Pp e630-e630 (2024)
Objectives: The existing biomarkers used to promptly identify graft dysfunction after kidney transplantation lack consistency. Neutrophil gelatinase-associated lipocalin (NGAL) appears to be a promising biomarker but its levels measured from serum an
Externí odkaz:
https://doaj.org/article/c7000871dc8f41ab99ef259830b9ebef
Publikováno v:
F1000Research, Vol 11 (2024)
Background The occurrence rate of stage 5 chronic kidney disease (CKD) will be 151 per million population in India in the coming years. Comorbidities like diabetes mellitus and hypertension are the usual triggers of CKD. Hence this study aimed to con
Externí odkaz:
https://doaj.org/article/2f7eeae618864fb29b420d16cb4ffe6b
Autor:
Saurabh M. Thanekar, Vishal Shanbhag, Attur Ravindra Prabhu, Shankar Prasad Nagaraju, Dharshan Rangaswamy, Srinivas Vinayak Shenoy, Mohan Varadarayanahalli Bhojaraja, Indu Ramachandra Rao
Publikováno v:
Critical Care Research and Practice, Vol 2024 (2024)
Conclusion: Hypochloremia, but not hyperchloremia, was associated with MAKE30 in this cohort of critically ill patients with sepsis.
Externí odkaz:
https://doaj.org/article/bc3fcdc9d10d48709f0ce6182a74dbba
Autor:
Jarupala Gangadhar Naik, Sreedhar Dharmagadda, Virendra S. Ligade, Shankar Prasad Nagaraju, Manjunath Kulkarni
Publikováno v:
Clinical Epidemiology and Global Health, Vol 24, Iss , Pp 101412- (2023)
Background: End-stage renal disease (ESRD) consequences have reached epidemic proportions in India, and disease rates are expected to rise further. Every year, around 0.22 million new patients with renal diseases are diagnosed in India. ESRD poses a
Externí odkaz:
https://doaj.org/article/4f28dd85ec0b4b98bc093d65d0cba218
Autor:
Shankar Prasad Nagaraju, Srinivas Vinayak Shenoy, Indu Rao, Ravindra Attur Prabhu, Dharshan Rangaswamy, Mohan V. Bhojaraja, Vasudeva Guddattu
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 34, Iss 4, Pp 279-287 (2023)
Hyperuricemia is a risk factor for the progression of chronic kidney disease (CKD). We compared febuxostat versus allopurinol in the progression of CKD and hyperuricemia in 101 patients with Stage 3–4 CKD treated with febuxostat or allopurinol for
Externí odkaz:
https://doaj.org/article/b2e3c33dddda43dbb33b2ee3a34b06f8
Publikováno v:
Nefrología (English Edition), Vol 42, Iss 5, Pp 531-539 (2022)
Frailty is common in end stage renal disease (ESRD) and is a marker of poor outcomes. Its prevalence increases as chronic kidney disease (CKD) progresses. There are different measurement tools available to assess frailty in ESRD. The pathogenesis of
Externí odkaz:
https://doaj.org/article/387d5a92e4804097b2efdd206da0b7dc
Autor:
Mohan V Bhojaraja, Ravindra Attur Prabhu, Shankar Prasad Nagaraju, Indu Ramachandra Rao, Srinivas Vinayak Shenoy, Dharshan Rangaswamy, Veena Natti Krishna, Megha Nagaraj Nayak
Publikováno v:
Journal of Nephropharmacology, Vol 12, Iss 2, Pp e10475-e10475 (2023)
Introduction: In hemodialysis (HD) patients, catheter-related bloodstream infections (CRBSI) cause significant morbidity and mortality. Objectives: We analyzed dialysis CRBSI incidence, associated factors, and the spectrum of the causative organisms.
Externí odkaz:
https://doaj.org/article/7c97cdae399b4391803c1e9ce8719ab7